LALPATHLAB Dr. Lal Pathlabs Limited
Healthcare
LTP
1,913.3
CHG · %
-7.45 (-0.39%)
VOL · TODAY
2.09L
PREV CLOSE
1,920.75
Today's range1,892 · 1,922.35
1,913.3
52-week range1,272.6 · 2,038.6
1,913.3
Loading candles…
Dr. Lal PathLabs Limited is a healthcare company in India with a history of over 75 years. It operates in the consumer healthcare, diagnostic services, and healthcare industries. The company provides diagnostic and related healthcare tests, including pathology and radiology tests and core testing services. Its offerings support patient diagnosis, prevention, monitoring, and treatment of diseases and other health conditions. Dr. Lal PathLabs serves individual patients, hospitals, healthcare providers, and corporate clients through an integrated nationwide network. No information on incorporation details, founders, key management, subsidiaries, or stock listings is available.
LALPATHLAB is not part of any active scan today.
This page is a live market overview for Dr. Lal Pathlabs Limited (LALPATHLAB) on the BSE. As a listed security, Dr. Lal Pathlabs Limited is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for LALPATHLAB before placing trades on tick2trade.
As of the latest feed, LALPATHLAB last traded at ₹1,913.3 on BSE, down ₹7.45 (0.39%) from the previous close of ₹1,920.75. Today's session range is ₹1,892 – ₹1,922.35, against a 52-week band of ₹1,272.6 – ₹2,038.6. Traded volume today stands at 2.09L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for LALPATHLAB in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether LALPATHLAB is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for Dr. Lal Pathlabs Limited before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in LALPATHLAB. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated LALPATHLAB option chain page linked from this overview.
// similar in healthcare326 total